Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Breen

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Journal of Parkinson'S Disease|May 24, 2021
Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson's Disease in the ICICLE-PD CohortRachael A Lawson, Caroline H Williams-Gray, Marta Camacho, et al.
Sleep|January 23, 2019
Sleep and cognitive aging in the eighth decade of lifeSimon R Cox, Stuart J Ritchie, Mike Allerhand, et al.
Parkinsonism & Related Disorders|April 21, 2016
Cognitive decline and quality of life in incident Parkinson's disease: The role of attentionRachael A Lawson, Alison J Yarnall, Gordon W Duncan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 22, 2016
Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)Caroline H Williams-Gray, Ruwani Wijeyekoon, Alison J Yarnall, et al.
Lung Cancer (Amsterdam, Netherlands)|November 28, 2017
Esophageal ultrasound (EUS) assessment of T4 status in NSCLC patientsJolanda C Kuijvenhoven, Laurence Crombag, David P Breen, et al.
Movement Disorders Clinical Practice|September 30, 2025
Managing Dystonia in Partington SyndromeEmilie Pichon, Aurea Alioth, Sabina Catalano Chiuvé, et al.
Frontiers in Aging Neuroscience|September 16, 2021
The Cerebrospinal Fluid Profile of Cholesterol Metabolites in Parkinson's Disease and Their Association With Disease State and Clinical FeaturesWilliam J Griffiths, Jonas Abdel-Khalik, Sarah F Moore, et al.
Brain, Behavior, and Immunity|February 2, 2020
Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's diseaseRuwani S Wijeyekoon, Deborah Kronenberg-Versteeg, Kirsten M Scott, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 13, 2025
Cognitive profiles at presentation and subsequent cognitive decline and quality of life in Parkinson's diseaseSaira S Mirza, Sarah Duff-Canning, Mark Mapstone, et al.
Neurology|May 7, 2013
Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson diseaseGavin Hudson, Mike Nalls, Jonathan R Evans, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Journal of Parkinson'S Disease|May 24, 2021
Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson's Disease in the ICICLE-PD CohortRachael A Lawson, Caroline H Williams-Gray, Marta Camacho, et al.
Sleep|January 23, 2019
Sleep and cognitive aging in the eighth decade of lifeSimon R Cox, Stuart J Ritchie, Mike Allerhand, et al.
Parkinsonism & Related Disorders|April 21, 2016
Cognitive decline and quality of life in incident Parkinson's disease: The role of attentionRachael A Lawson, Alison J Yarnall, Gordon W Duncan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 22, 2016
Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)Caroline H Williams-Gray, Ruwani Wijeyekoon, Alison J Yarnall, et al.
Lung Cancer (Amsterdam, Netherlands)|November 28, 2017
Esophageal ultrasound (EUS) assessment of T4 status in NSCLC patientsJolanda C Kuijvenhoven, Laurence Crombag, David P Breen, et al.
Movement Disorders Clinical Practice|September 30, 2025
Managing Dystonia in Partington SyndromeEmilie Pichon, Aurea Alioth, Sabina Catalano Chiuvé, et al.
Frontiers in Aging Neuroscience|September 16, 2021
The Cerebrospinal Fluid Profile of Cholesterol Metabolites in Parkinson's Disease and Their Association With Disease State and Clinical FeaturesWilliam J Griffiths, Jonas Abdel-Khalik, Sarah F Moore, et al.
Brain, Behavior, and Immunity|February 2, 2020
Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's diseaseRuwani S Wijeyekoon, Deborah Kronenberg-Versteeg, Kirsten M Scott, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 13, 2025
Cognitive profiles at presentation and subsequent cognitive decline and quality of life in Parkinson's diseaseSaira S Mirza, Sarah Duff-Canning, Mark Mapstone, et al.
Neurology|May 7, 2013
Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson diseaseGavin Hudson, Mike Nalls, Jonathan R Evans, et al.
Pageof 10